While FGFR1-4 alterations have been described in many cancers, FGFR2 fusions are particularly enriched in iCCA, occurring in 5–15% of cases, although there have been reports as high as 45% [17,19,25,26,27,28,29]. Here, FGFR2 is linked to cancer.